NO314231B1 - Meioseregulerende forbindelser og anvendelse derav til fremstilling av medikamenter - Google Patents
Meioseregulerende forbindelser og anvendelse derav til fremstilling av medikamenter Download PDFInfo
- Publication number
- NO314231B1 NO314231B1 NO19976044A NO976044A NO314231B1 NO 314231 B1 NO314231 B1 NO 314231B1 NO 19976044 A NO19976044 A NO 19976044A NO 976044 A NO976044 A NO 976044A NO 314231 B1 NO314231 B1 NO 314231B1
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- dien
- carbon atoms
- attached
- denotes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK73095 | 1995-06-23 | ||
| DK72895 | 1995-06-23 | ||
| DK146195 | 1995-12-22 | ||
| PCT/DK1996/000273 WO1997000884A1 (en) | 1995-06-23 | 1996-06-21 | Meiosis regulating compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO976044D0 NO976044D0 (no) | 1997-12-22 |
| NO976044L NO976044L (no) | 1998-02-20 |
| NO314231B1 true NO314231B1 (no) | 2003-02-17 |
Family
ID=27220892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19976044A NO314231B1 (no) | 1995-06-23 | 1997-12-22 | Meioseregulerende forbindelser og anvendelse derav til fremstilling av medikamenter |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0857173B1 (de) |
| JP (1) | JPH11507929A (de) |
| KR (1) | KR19990028366A (de) |
| CN (1) | CN1191543A (de) |
| AR (1) | AR003441A1 (de) |
| AT (1) | ATE254628T1 (de) |
| AU (1) | AU718246B2 (de) |
| BR (1) | BR9608968A (de) |
| CA (1) | CA2224866A1 (de) |
| CZ (1) | CZ408097A3 (de) |
| DE (1) | DE69630802T2 (de) |
| HU (1) | HUP9900454A3 (de) |
| IL (1) | IL122609A0 (de) |
| NO (1) | NO314231B1 (de) |
| PL (1) | PL185622B1 (de) |
| RU (1) | RU2182909C2 (de) |
| TW (1) | TW474943B (de) |
| WO (1) | WO1997000884A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL337008A1 (en) * | 1997-05-16 | 2000-07-31 | Akzo Nobel Nv | Derivatives of 20-aralkyl-5alpha-pregnane |
| DE69804611T2 (de) | 1997-06-04 | 2002-10-02 | Akzo Nobel N.V., Arnheim/Arnhem | 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose |
| ES2181321T3 (es) * | 1997-12-18 | 2003-02-16 | Akzo Nobel Nv | Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano. |
| EP0957108A1 (de) * | 1998-05-14 | 1999-11-17 | Schering Aktiengesellschaft | Ungesättigte Cholestan-derivate zur Regulierung von Meiose und pharmazeutische Präparate davon |
| IL139241A0 (en) | 1998-05-13 | 2001-11-25 | Novo Nordisk As | Meiosis regulating compounds |
| KR20010053031A (ko) * | 1998-06-19 | 2001-06-25 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 감수분열 조절 화합물 |
| ATE225366T1 (de) | 1998-12-11 | 2002-10-15 | Akzo Nobel Nv | 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität |
| WO2000036132A1 (en) * | 1998-12-14 | 2000-06-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
| CZ20012866A3 (cs) * | 1999-02-10 | 2002-01-16 | Schering Aktiengesellschaft | Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu |
| EP1156822B1 (de) * | 1999-02-24 | 2006-02-08 | Novo Nordisk A/S | In vitro methode zur synchronisation von oozytenreifung |
| CZ20012968A3 (cs) | 1999-02-24 | 2002-01-16 | Novo Nordisk A/S | Léčení neplodnosti |
| ATE306942T1 (de) | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
| EP1127890A1 (de) | 2000-02-22 | 2001-08-29 | Schering Aktiengesellschaft | Steroid Derivate mit einem an Ring A des Steroidgerüstes kondensierten Ring zur Regulierung der Meiose |
| MXPA02007818A (es) * | 2000-02-25 | 2002-10-23 | Schering Ag | Tasa de implantacion mejorada utilizando ff-mas. |
| EP1245572A1 (de) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung |
| WO2006047022A1 (en) | 2004-10-25 | 2006-05-04 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| US8399441B2 (en) | 2004-10-25 | 2013-03-19 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis |
| FR2898272B1 (fr) * | 2006-03-09 | 2008-07-04 | Trophos Sa | Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur |
| CN102258004B (zh) * | 2010-05-27 | 2013-07-17 | 中国科学院动物研究所 | 一种体外保存/培养卵母细胞以抑制卵母细胞生发泡破裂的方法 |
| US9034859B2 (en) | 2011-04-06 | 2015-05-19 | Virginia Commonwealth University | Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation |
| RS64332B1 (sr) | 2011-09-08 | 2023-08-31 | Sage Therapeutics Inc | Neuroaktivni steroidi, kompozicije i njihova upotreba |
| DK3461834T3 (da) | 2013-03-13 | 2021-08-23 | Sage Therapeutics Inc | Neuroaktive steroider |
| WO2015100312A1 (en) | 2013-12-24 | 2015-07-02 | Virginia Commonwealth University | Uses of oxygenated cholesterol sulfates (ocs) |
| WO2015195967A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| EA024619B1 (ru) * | 2014-11-21 | 2016-10-31 | Эльвин Гаджи оглы Керимли | ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ |
| MD3319612T2 (ro) | 2015-07-06 | 2021-10-31 | Sage Therapeutics Inc | Oxisteroli și metode de utilizare a acestora |
| KR102703602B1 (ko) | 2015-07-06 | 2024-09-06 | 세이지 테라퓨틱스, 인크. | 옥시스테롤 및 그의 사용 방법 |
| JP6882996B2 (ja) | 2015-07-06 | 2021-06-02 | セージ セラピューティクス， インコーポレイテッド | オキシステロールおよびそれらの使用の方法 |
| HRP20220716T1 (hr) | 2016-04-01 | 2022-09-02 | Sage Therapeutics, Inc. | Oksisteroli i postupci za njihovu uporabu |
| WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| RS62222B1 (sr) | 2016-07-07 | 2021-09-30 | Sage Therapeutics Inc | 24-hidroksisteroli supstituisani na poziciji 11 za upotrebu u lečenju stanja povezanih sa nmda |
| EA201990438A1 (ru) | 2016-08-02 | 2019-08-30 | Вирджиния Коммонвелт Юниверсити | Композиции, содержащие 5-холестен-3,25-диол, 3-сульфат (25hc3s) или его фармацевтически приемлемую соль и по меньшей мере один циклический олигосахарид, и способы их применения |
| PT3519422T (pt) | 2016-09-30 | 2022-12-05 | Sage Therapeutics Inc | Oxisteróis substituídos em c7 e métodos como moduladores nmda |
| KR20250054838A (ko) | 2016-10-18 | 2025-04-23 | 세이지 테라퓨틱스, 인크. | 옥시스테롤 및 그의 사용 방법 |
| KR102583278B1 (ko) | 2016-10-18 | 2023-09-27 | 세이지 테라퓨틱스, 인크. | 옥시스테롤 및 그의 사용 방법 |
| CN112430251A (zh) * | 2020-11-23 | 2021-03-02 | 广州瀚信通信科技股份有限公司 | 一种治疗白内障的化合物及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716777A (en) * | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
-
1996
- 1996-06-21 AT AT96918629T patent/ATE254628T1/de not_active IP Right Cessation
- 1996-06-21 RU RU98101093/04A patent/RU2182909C2/ru not_active IP Right Cessation
- 1996-06-21 CZ CZ974080A patent/CZ408097A3/cs unknown
- 1996-06-21 PL PL96324219A patent/PL185622B1/pl unknown
- 1996-06-21 JP JP9503527A patent/JPH11507929A/ja not_active Ceased
- 1996-06-21 AU AU61227/96A patent/AU718246B2/en not_active Ceased
- 1996-06-21 CN CN96195802A patent/CN1191543A/zh active Pending
- 1996-06-21 EP EP96918629A patent/EP0857173B1/de not_active Expired - Lifetime
- 1996-06-21 CA CA002224866A patent/CA2224866A1/en not_active Abandoned
- 1996-06-21 IL IL12260996A patent/IL122609A0/xx unknown
- 1996-06-21 BR BR9608968A patent/BR9608968A/pt unknown
- 1996-06-21 KR KR1019970709682A patent/KR19990028366A/ko not_active Ceased
- 1996-06-21 WO PCT/DK1996/000273 patent/WO1997000884A1/en not_active Ceased
- 1996-06-21 HU HU9900454A patent/HUP9900454A3/hu unknown
- 1996-06-21 DE DE69630802T patent/DE69630802T2/de not_active Expired - Fee Related
- 1996-06-24 AR ARP960103295A patent/AR003441A1/es unknown
- 1996-07-10 TW TW085108332A patent/TW474943B/zh not_active IP Right Cessation
-
1997
- 1997-12-22 NO NO19976044A patent/NO314231B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69630802T2 (de) | 2004-08-12 |
| EP0857173B1 (de) | 2003-11-19 |
| HUP9900454A3 (en) | 1999-11-29 |
| PL324219A1 (en) | 1998-05-11 |
| HUP9900454A2 (hu) | 1999-06-28 |
| CA2224866A1 (en) | 1997-01-09 |
| MX9800123A (es) | 1998-03-29 |
| WO1997000884A1 (en) | 1997-01-09 |
| CZ408097A3 (cs) | 1998-06-17 |
| IL122609A0 (en) | 1998-08-16 |
| PL185622B1 (pl) | 2003-06-30 |
| NO976044D0 (no) | 1997-12-22 |
| NO976044L (no) | 1998-02-20 |
| BR9608968A (pt) | 1999-06-29 |
| AU718246B2 (en) | 2000-04-13 |
| ATE254628T1 (de) | 2003-12-15 |
| KR19990028366A (ko) | 1999-04-15 |
| TW474943B (en) | 2002-02-01 |
| AU6122796A (en) | 1997-01-22 |
| JPH11507929A (ja) | 1999-07-13 |
| CN1191543A (zh) | 1998-08-26 |
| DE69630802D1 (de) | 2003-12-24 |
| EP0857173A1 (de) | 1998-08-12 |
| RU2182909C2 (ru) | 2002-05-27 |
| AR003441A1 (es) | 1998-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO314231B1 (no) | Meioseregulerende forbindelser og anvendelse derav til fremstilling av medikamenter | |
| US6645953B2 (en) | Meiosis regulating compounds | |
| US6407086B2 (en) | Meiosis regulating compounds | |
| FI117159B (fi) | Sterolijohdosten käyttö meioosin säätelyyn | |
| NO313144B1 (no) | Meioseregulerende forbindelser og anvendelse derav til fremstilling av medikamenter | |
| KR20010012643A (ko) | 20-아랄킬-5α-프레그난 유도체 | |
| EP1077992B1 (de) | Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren | |
| JP2002539134A (ja) | 減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体 | |
| RU2289587C2 (ru) | Стероидные соединения, способы их получения, фармацевтическая композиция, способы регуляции и совершенствования воспроизведения, промежуточные соединения | |
| MXPA98000123A (en) | Compounds that regulate the meio | |
| EP0957108A1 (de) | Ungesättigte Cholestan-derivate zur Regulierung von Meiose und pharmazeutische Präparate davon | |
| HUP0102704A2 (hu) | Meiózist befolyásoló szteroidok és alkalmazásuk | |
| EP1514874A1 (de) | Thiomorpholinosteroidverbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Arzneimittel und ein Verfahren zu ihrer Herstellung | |
| MXPA06001145A (en) | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof | |
| MXPA00011133A (en) | Meiosis regulating compounds | |
| CZ20004566A3 (cs) | Nové sloučeniny, jejich použití, způsob regulace meiózy a nový znak |